From: The role of specific biomarkers, as predictors of post-operative complications following flexible ureterorenoscopy (FURS), for the treatment of kidney stones: a single-centre observational clinical pilot-study in 37 patients
Main constituent of stone(s)
Patients
Calcium oxalate monohydrate
21
Calcium phosphate stones
7
Cystine stones
3
Calcium hydroxyl phosphate
Calcium-oxalate dihydrate stones